Anderson R E, Woodbury D M
Epilepsia. 1984 Dec;25(6):773-8. doi: 10.1111/j.1528-1157.1984.tb03490.x.
Diphenylhydantoin (phenytoin) added to cultures of osteoblast-like cells at a concentration of 10 microM, at the high end of the therapeutic range in plasma of unbound phenytoin (4-8 microM), caused reductions in Na+, K+-ATPase and alkaline phosphatase activities and increases in Ca2+-ATPase and HCO3--ATPase activities in homogenates of whole cells and in subcellular fractions of cultured osteoblast-like cells. These data suggest that, if these changes occur in vivo, the osteomalacia associated with treatment with diphenylhydantoin may be mediated in part by direct effects on the ability of bone cells to transport ions.
将二苯乙内酰脲(苯妥英)以10微摩尔的浓度添加到成骨样细胞培养物中,该浓度处于未结合苯妥英血浆治疗范围的高端(4 - 8微摩尔),这导致全细胞匀浆以及培养的成骨样细胞亚细胞组分中钠钾ATP酶和碱性磷酸酶活性降低,而钙ATP酶和碳酸氢根ATP酶活性增加。这些数据表明,如果这些变化发生在体内,与二苯乙内酰脲治疗相关的骨软化症可能部分是由对骨细胞离子转运能力的直接影响所介导的。